共 50 条
Nucleophosmin 1 Mutations in Acute Myeloid Leukemia
被引:45
作者:
Zarka, Jabra
[1
]
Short, Nicholas J.
[1
]
Kanagal-Shamanna, Rashmi
[2
]
Issa, Ghayas C.
[1
]
机构:
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
来源:
关键词:
AML;
nucleophosmin (NPM1);
gene expression;
targeted therapies;
TUMOR-SUPPRESSOR PROTEIN;
ACUTE MYELOGENOUS LEUKEMIA;
MINIMAL RESIDUAL DISEASE;
GENE-EXPRESSION PROFILE;
NPM1;
MUTATIONS;
CLONAL HEMATOPOIESIS;
MUTANT NUCLEOPHOSMIN;
RIBOSOME BIOGENESIS;
RETINOIC ACID;
CYTOPLASMIC NUCLEOPHOSMIN;
D O I:
10.3390/genes11060649
中图分类号:
Q3 [遗传学];
学科分类号:
071007 ;
090102 ;
摘要:
Nucleophosmin (NPM1) is a ubiquitously expressed nucleolar protein involved in ribosome biogenesis, the maintenance of genomic integrity and the regulation of the ARF-p53 tumor-suppressor pathway among multiple other functions. Mutations in the corresponding gene cause a cytoplasmic dislocation of the NPM1 protein. These mutations are unique to acute myeloid leukemia (AML), a disease characterized by clonal expansion, impaired differentiation and the proliferation of myeloid cells in the bone marrow. Despite our improved understanding ofNPM1mutations and their consequences, the underlying leukemia pathogenesis is still unclear. Recent studies that focused on dysregulated gene expression in AML with mutatedNPM1have shed more light into these mechanisms. In this article, we review the current evidence on normal functions of NPM1 and aberrant functioning in AML, and highlight investigational strategies targeting these mutations.
引用
收藏
页码:1 / 16
页数:16
相关论文